- Home
- HYFT vs MBOT Comparison
HYFT vs MBOT Comparison
Compare HYFT & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HYFT | MBOT |
|---|---|---|
| Founded | 1983 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.1M | 75.2M |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | HYFT | MBOT |
|---|---|---|
| Price | $1.49 | $1.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $4.33 | ★ $6.33 |
| AVG Volume (30 Days) | 323.6K | ★ 609.5K |
| Earning Date | 09-14-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | $12.86 | N/A |
| Revenue Next Year | $22.94 | $475.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $1.05 |
| 52 Week High | $3.00 | $3.04 |
Technical Indicators
Market Signals| Indicator | HYFT | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 57.31 | 22.40 |
| Support Level | $1.23 | N/A |
| Resistance Level | $1.50 | $2.21 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 40.00 | 4.41 |
Price Performance
Historical ComparisonAbout HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.